Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANITA ABRAHAM

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1558380337
CMS profile
464460
Location
STOCKTON, CA

General Payments · PY2018–2024

$1,165.38

  • Reported across 36 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$454.97

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $454.97 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
BETA BIONICS, INC. $268.41 5
Medtronic, Inc. $57.19 3
GlaxoSmithKline, LLC. $43.53 2
Amgen Inc. $27.91 1
Novo Nordisk AS $20.99 1
DEXCOM, INC. $20.24 1
Abbott Laboratories $16.70 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $435.96 12
PY2019 $186.50 5
PY2020 $16.57 1
PY2021 $19.19 1
PY2022 $14.54 1
PY2023 $37.65 2
PY2024 $454.97 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $16.70 01/29/2024 Food and Beverage Undisputed 01/23/2026 1125123439 CMS
Amgen Inc. $27.91 11/08/2024 Food and Beverage Undisputed 01/23/2026 1111508443 CMS
BETA BIONICS, INC. $23.76 01/04/2024 Food and Beverage Undisputed 01/23/2026 1087873403 CMS
BETA BIONICS, INC. $34.37 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087877633 CMS
BETA BIONICS, INC. $156.03 06/04/2024 Food and Beverage Undisputed 01/23/2026 1087877639 CMS
BETA BIONICS, INC. $31.40 10/18/2024 Food and Beverage Undisputed 01/23/2026 1087885323 CMS
BETA BIONICS, INC. $22.85 12/16/2024 Food and Beverage Undisputed 01/23/2026 1087888951 CMS
Dexcom, Inc. $20.24 04/16/2024 Food and Beverage Undisputed 01/23/2026 1153280237 CMS
GlaxoSmithKline, LLC. $21.84 05/02/2024 Food and Beverage Undisputed 01/23/2026 1115774935 CMS
GlaxoSmithKline, LLC. $21.69 06/12/2024 Food and Beverage Undisputed 01/23/2026 1116337063 CMS
Medtronic, Inc. $13.15 03/22/2024 Food and Beverage Undisputed 01/23/2026 1119374060 CMS
Medtronic, Inc. $19.61 09/11/2024 Food and Beverage Undisputed 01/23/2026 1119374064 CMS
Medtronic, Inc. $24.43 10/03/2024 Food and Beverage Undisputed 01/23/2026 1119374062 CMS
Novo Nordisk Inc $20.99 11/21/2024 Food and Beverage Undisputed 01/23/2026 1097414988 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.